Table 1 Association between MAD2L1 and CCNB2 protein expression and patient clinical characteristics
Patient characteristics | n (%) | MAD2L1 | P-value | CCNB2 | P-value | ||
|---|---|---|---|---|---|---|---|
Low expression, n (%) | High expression, n (%) | Low expression, n (%) | High expression, n (%) | ||||
Gender | |||||||
 Male | 21 (63.6) | 9 (42.9) | 12 (57.1) | 0.457 | 8 (38.1) | 13 (61.9) | 0.259 |
 Female | 12 (36.4) | 3 (25) | 9 (75) |  | 2 (16.7) | 10 (83.3) |  |
Age (years) | |||||||
 ≤ 5 | 7 (21.2) | 5 (71.4) | 2 (28.6) | 0.071 | 4 (57.1) | 3 (42.9) | 0.161 |
 > 5 | 26 (78.8) | 7 (26.9) | 19 (73.1) |  | 6 (23.1) | 20 (76.9) |  |
Tumor diameter | |||||||
 ≤ 5 cm | 11 (33.3) | 4 (36.4) | 7 (63.6) | 1.000 | 8 (72.7) | 3 (27.3) | 0.000a |
 > 5 cm | 22 (66.7) | 8 (36.4) | 14 (63.6) |  | 2 (9.1) | 20 (90.9) |  |
Histology | |||||||
 ERMS | 14 (42.4) | 7 (50) | 7 (50) | 0.427 | 5 (35.7) | 9 (64.3) | 0.164 |
 ARMS | 12 (36.4) | 3 (25) | 9 (75) |  | 5 (41.7) | 7 (58.3) |  |
 PRMS | 7 (21.2) | 2 (28.6) | 5 (71.4) |  | 0 (0.0) | 7 (100.0) |  |
Location | |||||||
 Head and neck | 9 (27.3) | 3 (33.3) | 6 (66.7) | 1.000 | 4 (44.4) | 5 (55.6) | 0.943 |
 Torso and limbs | 16 (48.5) | 6 (37.5) | 10 (62.5) |  | 5 (31.3) | 11 (68.7) |  |
 Urinary | 5 (15.2) | 2 (40) | 3 (60) |  | 2 (40) | 3 (60) |  |
 Abdominal or retroperitoneal | 3 (9) | 1 (33.3) | 2 (66.7) |  | 1 (33.3) | 2 (66.7) |  |